 |
| PSIDD is On Fire Today: Major News Out |
|
 Yesterday's Top Performer |
Company: Marley Coffee (OTCBB: JAMN)
|
End of Day:
Price: 0.28
Change (%): + 0.04 (16.67)
Volume: 234,709 |
 |
Marley Coffee (corporate name Jammin Java Corp) is a US-based company that provides premium, artisan roasted coffee to the grocery, retail, online, service, hospitality, office coffee service and big box store industry. Under its exclusive licensing agreement with 56 Hope Road, the company continues to develop its coffee lines under the Marley Coffee brand. Marley Coffee is a fully reporting company quoted on the OTCBB under the symbol JAMN.
Company Information Sheet
|
 Hot Stock to Watch
|
Company: PositiveID Corporation (OTCBB: PSIDD)
|
Last:
Price: 0.57
Change (%): + 0.103 (22.06)
Volume: 164,194 |
 |
Photo Release - PositiveID Corporation Launches Development of Firefly Dx to Confirm Biological Threats in the Field Within Minutes
To Be Used in the Identification of Biological Agents Associated With Weapons of Mass Destruction, Point-of-Need Monitoring of Pathogenic Outbreaks and Agricultural Screening
DELRAY BEACH, Fla., April 29, 2013 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSIDD), a developer of biological detection and diagnostics solutions, today announced it has launched the development of the Firefly Dx detection system (“Firefly”), a portable, hand-held, point-of-need molecular diagnostic system, which is being designed to provide test results from sample input through reporting of results in less than 15 to 30 minutes depending on the type of test performed. Firefly is expected to quickly process human and agricultural samples to provide accurate confirmation of biological threats via a smart-phone application.
Continue Reading |
Other Small Cap News
|
Company: Andain Inc. (OTCBB: ANDN)
|
Andain Inc. Announces its Innovative Organ-targeted Drug Delivery Nano-particles
ARAD, Israel, April 29, 2013 /PRNewswire/ -- Andain Inc. (OTCBB: ANDN) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its accelerating incubator program, announces today its innovative nano-particles drug delivery technology.
Andain completed the development of innovative lipid-based drug delivery nano-particles capable of carrying hydrophilic and hydrophobic drugs to a targeted human organ with timely drug release capabilities. After the nano-particles release the drug directly to the targeted organ, they brake-down to their natural ingredients and are absorbed into the natural metabolism with no adverse affects.
Continue Reading
|
Company: MediSwipe Inc. (OTCBB: MWIP)
|
MediSwipe Inc. Announces MediSwipe DMS - Digital Patient Management and Tracking Software for Dispensaries, Provisional Centers and Caregivers Now Available to Register for Online Trial at www.MediSwipe.com
Company Continues to Complete Installations of MediSwipe DMS in Detroit and Ann Arbor Throughout Weekend With Appearance as Feature MMJ Company at Monroe State Fair "Hash Bash" in Ann Arbor
LOS ANGELES, April 5, 2013 (GLOBE NEWSWIRE) -- MediSwipe Inc. (www.MediSwipe.com) (MWIP), a patient security solutions and financial products company for the medicinal marijuana and health care industry, today announced that the Company's proprietary digital patient management and tracking software application developed for the medicinal marijuana sector "MediSwipe DMS", is now available to patients, caregivers and dispensaries to sign up and trial at www.MediSwipe.com. Those seeking to test the system must click on the banner and register to receive a log-in for the system. The MediSwipe DMS application includes patient registration, digital records management and tracking of all caregiver transactions including log-in time, date stamp and quantity and type of medication. Users under agreement will pay monthly licensing fees for access to the program.
Continue Reading |
Market News
|
By Jon Hilsenrath: The Wall Street Journal
|
Tame Inflation to Keep Fed on Course
Federal Reserve officials are likely to continue their easy-money policies at the central bank's policy meeting on Tuesday and Wednesday, in part because several recent inflation measures have fallen well below the Fed's 2% target.
With inflation now lower than the Fed wants, officials are likely to conclude their policies show no sign of overheating the economy. That allows them to maintain their 85 billion-a-month bond-buying program, which the central bank is employing to ease credit conditions and spur spending, investment and hiring.
Fed officials after their March policy meeting talked about tapering off the bond purchases later this year if the economy continued to gain strength. But inflation readings have since slipped, and employment numbers have been disappointing.
Continue Reading
|
By Matt Nesto: Breakout
|
Earnings Season Volatility Has Investors Scrambling for Short-Term Trades
I like to call them the disaster du jour. It's when a particular stock gets crushed after missing analyst expectations or gets slammed for perhaps sounding more cautious than optimistic in giving its purview of the future. As jarring as these double-digit dips are for existing shareholders, they can also be pure gold for investors who are quick enough to react when they think the punishment does not fit the crime.
"Whether they miss here or miss there, that's not going to change the arithmetic of how they create value for investors over the long term," says Martin Leclerc, managing partner at Barrack Yard Advisors of IBM's recent 10% post-earnings dive.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
